Targeting the translation machinery in cancer

Nature Reviews. Drug Discovery
Mamatha BhatIvan Topisirovic

Abstract

Dysregulation of mRNA translation is a frequent feature of neoplasia. Many oncogenes and tumour suppressors affect the translation machinery, making aberrant translation a widespread characteristic of tumour cells, independent of the genetic make-up of the cancer. Therefore, therapeutic agents that target components of the protein synthesis apparatus hold promise as novel anticancer drugs that can overcome intra-tumour heterogeneity. In this Review, we discuss the role of translation in cancer, with a particular focus on the eIF4F (eukaryotic translation initiation factor 4F) complex, and provide an overview of recent efforts aiming to 'translate' these results to the clinic.

References

Oct 1, 1975·Antimicrobial Agents and Chemotherapy·J S Tscherne, S Pestka
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P BanerjeeJ Avruch
Oct 1, 1988·European Journal of Clinical Investigation·G OllenschlägerB Mödder
Apr 25, 1986·Cell·P P Mueller, A G Hinnebusch
Nov 15, 1995·The Biochemical Journal·F Buttgereit, M D Brand
Oct 5, 1995·Nature·E J BrownS L Schreiber
Jun 2, 1995·The Journal of Biological Chemistry·C S ChenR E Pagano
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I B RosenwaldE V Schmidt
Mar 15, 1996·International Journal of Cancer. Journal International Du Cancer·C G KevilJ S Alexander
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·S R von ManteuffelG Thomas
Oct 23, 1997·The Journal of Biological Chemistry·K HaraJ Avruch
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·P E BurnettD M Sabatini
Jul 31, 1998·Protein Science : a Publication of the Protein Society·C M Fletcher, G Wagner
Apr 27, 1999·The International Journal of Biochemistry & Cell Biology·B Raught, A C Gingras
Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C O NathanJ Glass
Jan 27, 2000·Cell·D Hanahan, R A Weinberg

❮ Previous
Next ❯

Citations

Feb 20, 2016·Blood·Alison Yeomans, Graham Packham
Jan 30, 2016·Blood·Jerome Paggetti, Etienne Moussay
Oct 24, 2015·The Plant Journal : for Cell and Molecular Biology·Maxwell S BushJohn H Doonan
Jun 24, 2016·Translation·Regina Cencic, Jerry Pelletier
Jun 18, 2016·Molecular & Cellular Oncology·Shuo Wang, Antonis E Koromilas
May 20, 2015·Biochimica Et Biophysica Acta·Ivan Topisirovic, Nahum Sonenberg
Apr 21, 2016·Cytokine·Ewa M KosciuczukLeonidas C Platanias
Apr 27, 2016·Nature Reviews. Cancer·Morgan L Truitt, Davide Ruggero
May 12, 2016·Biochimica Et Biophysica Acta·Michael M KunzeTobias Schmid
May 20, 2016·Gene·Yanbin LiuLiang Chen
Jun 15, 2016·Scientific Reports·Irina V ProkhorovaSergey E Dmitriev
Jun 21, 2016·Nature Communications·Yoshinori TsukumoNahum Sonenberg
Jun 25, 2016·Chemistry : a European Journal·Wenyu WangJohn A Porco
Aug 17, 2016·Trends in Biochemical Sciences·Clive R BramhamChristopher G Proud
Aug 28, 2016·Cell Cycle·Yoshinori TsukumoTommy Alain
Sep 16, 2016·Nature·J Wade Harper, Eric J Bennett
Sep 20, 2016·The Journal of Clinical Investigation·Ekta KhattarVinay Tergaonkar
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Soroush TahmasebiNahum Sonenberg
Nov 11, 2016·Cell Cycle·Aude De Gassart, Fabio Martinon
Jul 19, 2016·Trends in Cell Biology·Jennifer ChuJerry Pelletier
Jan 17, 2017·IEEE Transactions on Nanobioscience·Anish BabuRajagopal Ramesh
Jan 27, 2017·Journal of the National Cancer Institute·Wanpei CaiAlan Prem Kumar
Feb 28, 2017·PLoS Genetics·Hyun Yong JinChangchun Xiao
Mar 10, 2017·ACS Applied Materials & Interfaces·Kian Ping ChanJames Chen Yong Kah
May 12, 2017·Science Translational Medicine·Salomon ManierIrene M Ghobrial
May 14, 2017·The FEBS Journal·Renu Tuteja
Jun 9, 2017·Nature Communications·Moiez AliKris C Wood
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Muhammad Umar AliCao Jiang
Feb 1, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alex G JohnsonJoseph D Puglisi
Feb 1, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jamie H D Cate
Jan 19, 2017·Annual Review of Medicine·Vera P Krymskaya, Francis X McCormack
May 18, 2016·Molecular & Cellular Proteomics : MCP·Joshua M GendronEric J Bennett
Mar 11, 2017·Current Opinion in Oncology·Vidya P RamamurthyVincent C O Njar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.